Annual EBIT
-$63.03 M
-$40.72 M-182.47%
31 December 2023
Summary:
Verrica Pharmaceuticals annual earnings before interest & taxes is currently -$63.03 million, with the most recent change of -$40.72 million (-182.47%) on 31 December 2023. During the last 3 years, it has fallen by -$23.37 million (-58.93%). VRCA annual EBIT is now -3194.98% below its all-time high of -$1.91 million, reached on 31 December 2016.VRCA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$20.48 M
-$5.67 M-38.24%
30 September 2024
Summary:
Verrica Pharmaceuticals quarterly earnings before interest & taxes is currently -$20.48 million, with the most recent change of -$5.67 million (-38.24%) on 30 September 2024. Over the past year, it has increased by +$2.66 million (+11.50%). VRCA quarterly EBIT is now -12590.24% below its all-time high of $164.00 thousand, reached on 30 September 2022.VRCA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$75.62 M
+$2.66 M+3.40%
30 September 2024
Summary:
Verrica Pharmaceuticals TTM earnings before interest & taxes is currently -$75.62 million, with the most recent change of +$2.66 million (+3.40%) on 30 September 2024. Over the past year, it has dropped by -$28.97 million (-62.09%). VRCA TTM EBIT is now -13167.19% below its all-time high of -$570.00 thousand, reached on 31 March 2017.VRCA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRCA EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -182.5% | +11.5% | -62.1% |
| 3 y3 years | -58.9% | -74.5% | -120.3% |
| 5 y5 years | -188.1% | -236.3% | -163.0% |
VRCA EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -182.5% | at low | <-9999.0% | +11.5% | -252.4% | +3.4% |
| 5 y | 5 years | -188.1% | at low | <-9999.0% | +11.5% | -252.4% | +3.4% |
| alltime | all time | -3195.0% | at low | <-9999.0% | +11.5% | <-9999.0% | +3.4% |
Verrica Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$20.48 M(+38.2%) | -$75.62 M(-3.4%) |
| June 2024 | - | -$14.82 M(-17.7%) | -$78.28 M(+5.1%) |
| Mar 2024 | - | -$18.01 M(-19.3%) | -$74.46 M(+18.1%) |
| Dec 2023 | -$63.03 M(+182.5%) | -$22.31 M(-3.6%) | -$63.03 M(+35.1%) |
| Sept 2023 | - | -$23.14 M(+110.6%) | -$46.66 M(+99.8%) |
| June 2023 | - | -$10.99 M(+66.8%) | -$23.35 M(+8.8%) |
| Mar 2023 | - | -$6.59 M(+11.1%) | -$21.46 M(-3.6%) |
| Dec 2022 | -$22.32 M(-27.5%) | -$5.93 M(-3717.1%) | -$22.26 M(-10.1%) |
| Sept 2022 | - | $164.00 K(-101.8%) | -$24.77 M(-32.5%) |
| June 2022 | - | -$9.10 M(+23.2%) | -$36.67 M(-4.2%) |
| Mar 2022 | - | -$7.39 M(-12.5%) | -$38.27 M(+24.3%) |
| Dec 2021 | -$30.79 M(-22.4%) | -$8.44 M(-28.1%) | -$30.79 M(-10.3%) |
| Sept 2021 | - | -$11.74 M(+9.7%) | -$34.33 M(+6.7%) |
| June 2021 | - | -$10.70 M(<-9900.0%) | -$32.16 M(+7.3%) |
| Mar 2021 | - | $92.00 K(-100.8%) | -$29.97 M(-24.4%) |
| Dec 2020 | -$39.66 M | -$11.98 M(+25.3%) | -$39.66 M(+12.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$9.57 M(+12.5%) | -$35.31 M(+10.9%) |
| June 2020 | - | -$8.51 M(-11.4%) | -$31.83 M(+5.0%) |
| Mar 2020 | - | -$9.60 M(+25.7%) | -$30.33 M(+7.5%) |
| Dec 2019 | -$28.21 M(+28.9%) | -$7.64 M(+25.4%) | -$28.21 M(-1.9%) |
| Sept 2019 | - | -$6.09 M(-13.0%) | -$28.76 M(-0.8%) |
| June 2019 | - | -$7.00 M(-6.4%) | -$29.00 M(+5.6%) |
| Mar 2019 | - | -$7.48 M(-8.7%) | -$27.47 M(+25.6%) |
| Dec 2018 | -$21.88 M(+390.9%) | -$8.19 M(+29.3%) | -$21.88 M(+44.7%) |
| Sept 2018 | - | -$6.33 M(+15.8%) | -$15.12 M(+49.0%) |
| June 2018 | - | -$5.47 M(+189.7%) | -$10.15 M(+75.8%) |
| Mar 2018 | - | -$1.89 M(+31.7%) | -$5.78 M(+29.6%) |
| Dec 2017 | -$4.46 M(+133.0%) | -$1.43 M(+5.6%) | -$4.46 M(+47.4%) |
| Sept 2017 | - | -$1.36 M(+24.0%) | -$3.02 M(+81.6%) |
| June 2017 | - | -$1.09 M(+92.1%) | -$1.67 M(+192.1%) |
| Mar 2017 | - | -$570.00 K | -$570.00 K |
| Dec 2016 | -$1.91 M | - | - |
FAQ
- What is Verrica Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals annual EBIT year-on-year change?
- What is Verrica Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals quarterly EBIT year-on-year change?
- What is Verrica Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals TTM EBIT year-on-year change?
What is Verrica Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of VRCA is -$63.03 M
What is the all time high annual EBIT for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high annual earnings before interest & taxes is -$1.91 M
What is Verrica Pharmaceuticals annual EBIT year-on-year change?
Over the past year, VRCA annual earnings before interest & taxes has changed by -$40.72 M (-182.47%)
What is Verrica Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of VRCA is -$20.48 M
What is the all time high quarterly EBIT for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high quarterly earnings before interest & taxes is $164.00 K
What is Verrica Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, VRCA quarterly earnings before interest & taxes has changed by +$2.66 M (+11.50%)
What is Verrica Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of VRCA is -$75.62 M
What is the all time high TTM EBIT for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high TTM earnings before interest & taxes is -$570.00 K
What is Verrica Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, VRCA TTM earnings before interest & taxes has changed by -$28.97 M (-62.09%)